Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
J. Connor Wells, Shubham Sharma, Joseph C. Del Paggio, et al.
JAMA Oncology (2021) Vol. 7, Iss. 3, pp. 379-379
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Priorities for cancer research in low- and middle-income countries: a global perspective
C.S. Pramesh, Rajendra Badwe, Nirmala Bhoo‐Pathy, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 649-657
Open Access | Times Cited: 270
Evolution of the Randomized Clinical Trial in the Era of Precision Oncology
Joseph C. Del Paggio, John Berry, Wilma M. Hopman, et al.
JAMA Oncology (2021) Vol. 7, Iss. 5, pp. 728-728
Open Access | Times Cited: 152
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
Adam Fundytus, Manju Sengar, Dorothy Lombe, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 10, pp. 1367-1377
Open Access | Times Cited: 116
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93
The Lancet Breast Cancer Commission
Charlotte E. Coles, Helena Earl, Benjamin O. Anderson, et al.
The Lancet (2024) Vol. 403, Iss. 10439, pp. 1895-1950
Open Access | Times Cited: 64
Common Sense Oncology: outcomes that matter
Christopher M. Booth, Manju Sengar, Aaron M. Goodman, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 8, pp. 833-835
Closed Access | Times Cited: 61
Radiotherapy and theranostics: a Lancet Oncology Commission
May Abdel‐Wahab, Francesco Giammarile, M. Carrara, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 11, pp. e545-e580
Closed Access | Times Cited: 34
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Mark Lawler, Lynne Davies, Simon Oberst, et al.
The Lancet Oncology (2022) Vol. 24, Iss. 1, pp. e11-e56
Open Access | Times Cited: 68
Economic Perspective of Cancer Care and Its Consequences for Vulnerable Groups
Jörg Haier, Juergen Schaefers
Cancers (2022) Vol. 14, Iss. 13, pp. 3158-3158
Open Access | Times Cited: 60
Participation of Lower and Upper Middle–Income Countries in Oncology Clinical Trials Led by High-Income Countries
Fidel Rubagumya, Wilma M. Hopman, Bishal Gyawali, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227252-e2227252
Open Access | Times Cited: 52
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
Chandrakanth Are, Shilpa S. Murthy, Richard Sullivan, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 12, pp. e472-e518
Closed Access | Times Cited: 41
Using system dynamics modeling approach to strengthen health systems to combat cancer: a systematic literature review
Xianwen Chen, Kuangyuan Cai, Yan Xue, et al.
Journal of Medical Economics (2025) Vol. 28, Iss. 1, pp. 168-185
Open Access | Times Cited: 1
Network analysis of cross-income-level collaboration on multiple myeloma in sub-Saharan Africa
Kai Yang, Sam Benkwitz-Bedford, Jean‐Baptiste Cazier, et al.
(2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
An urgent call to raise the bar in oncology
John‐John B. Schnog, Michael Samson, Rijk O. B. Gans, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 11, pp. 1477-1485
Open Access | Times Cited: 50
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
Kristina Jenei, Zeba Aziz, Christopher M. Booth, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 12, pp. e1860-e1866
Open Access | Times Cited: 38
Leveraging national and global political determinants of health to promote equity in cancer care
Edward Christopher Dee, Michelle Ann B Eala, Janine Patricia G Robredo, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 10, pp. 1157-1163
Open Access | Times Cited: 18
Global Equity in Clinical Trials: An ASCO Policy Statement
Sana Al‐Sukhun, Verna Vanderpuye, Carolyn Taylor, et al.
JCO Global Oncology (2024), Iss. 10
Open Access | Times Cited: 8
Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?
Rakesh Jalali, Angélica Nogueira‐Rodrigues, Arunangshu Das, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 3-10
Open Access | Times Cited: 28
Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials
Joanna Dodkins, Wilma M. Hopman, J. Connor Wells, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 113, Iss. 3, pp. 500-508
Open Access | Times Cited: 24
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
Gustavo Gössling, Taiane Francieli Rebelatto, Cynthia Villarreal‐Garza, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 653-662
Open Access | Times Cited: 16
Growing the global cancer care system: success stories from around the world and lessons for the future
Edward Christopher Dee, C.S. Pramesh, Christopher M. Booth, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 8, pp. 1193-1197
Open Access | Times Cited: 6
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities
May Abdel‐Wahab, C. Norman Coleman, Jesper Grau Eriksen, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e270-e280
Closed Access | Times Cited: 6
Why Research From Lower- and Middle-Income Countries Matters to Evidence-Based Intervention: A State of the Science Review of ACT Research as an Example
Baljinder K. Sahdra, G. King, Jennifer S. Payne, et al.
Behavior Therapy (2024) Vol. 55, Iss. 6, pp. 1348-1363
Open Access | Times Cited: 6
Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers
Laura Vidal, Zodwa Dlamini, Qian Shi, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103373-103373
Open Access | Times Cited: 5
Cancer as a Global Health Priority
Satish Gopal, Norman E. Sharpless
JAMA (2021) Vol. 326, Iss. 9, pp. 809-809
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top